Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

EFTREFTR
4 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in eFFECTOR Therapeutics, Inc.

Qube Research & Technologies Ltd previously held 0 shares of EFTR (eFFECTOR Therapeutics, Inc.), worth $0 as of 2024-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$38

Total Shares Change

-81

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q3
Latest
Exited
0
-100.0%
$00.0%$0.04
0
2024-Q2
Unchanged
3
0.0%
$10.0%$0.29
0
2024-Q1
Decreased
3
-96.3%
$430.0%$14.39
0
2023-Q4
New
81
-
$380.0%$11.69
17

Other major holders of EFTR: Blackstone Inc., Carlyle Group Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used